Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
+$437M |
| 2 |
AbbVie
ABBV
|
+$380M |
| 3 |
Workday
WDAY
|
+$366M |
| 4 |
Synopsys
SNPS
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$286M |
Top Sells
| 1 |
Adobe
ADBE
|
+$1.71B |
| 2 |
Apple
AAPL
|
+$984M |
| 3 |
Boston Scientific
BSX
|
+$642M |
| 4 |
Microsoft
MSFT
|
+$599M |
| 5 |
Texas Instruments
TXN
|
+$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Phathom Pharmaceuticals
PHAT
$874M
| $27.2M | 0.01% |
2,001,442
+160,085
| +9% | +$2.18M |
|
677
Bio-Rad Laboratories Class A
BIO
$7.49B
| $27.2M | 0.01% |
48,325
-21,323
| -31% | -$12M |
|
678
U-Haul Holding Co
UHAL
$10.8B
| $27.2M | 0.01% |
455,550
-36,660
| -7% | -$2.19M |
|
679
Carnival PLC
CUK
$37.5B
| $27.1M | 0.01% |
1,484,142
+174,594
| +13% | +$3.19M |
|
680
Booz Allen Hamilton
BAH
$12.6B
| $27M | 0.01% |
307,600
+27
| +0% | +$2.37K |
|
681
Norfolk Southern
NSC
$61.1B
| $26.7M | 0.01% |
93,488
+4,943
| +6% | +$1.41M |
|
682
Schlumberger
SLB
$53.9B
| $26.4M | 0.01% |
638,643
-52,385
| -8% | -$2.16M |
|
683
C4 Therapeutics
CCCC
$188M
| $26.4M | 0.01% |
1,086,782
+40,837
| +4% | +$991K |
|
684
Watts Water Technologies
WTS
$9.29B
| $26.3M | 0.01% |
188,438
-20,423
| -10% | -$2.85M |
|
|
VG
685
DELISTED
Vonage Holdings Corporation
VG
| $26.3M | 0.01% |
1,296,494
-8,503,716
| -87% | -$172M |
|
686
Patria Investments
PAX
$2.26B
| $26M | 0.01% |
1,460,236
-9,193
| -0.6% | -$164K |
|
687
Arthur J. Gallagher & Co
AJG
$75.2B
| $26M | 0.01% |
148,760
+44,984
| +43% | +$7.85M |
|
688
Century Casinos
CNTY
$75.1M
| $25.8M | 0.01% |
2,158,665
-4,686
| -0.2% | -$56K |
|
689
Philip Morris
PM
$257B
| $25.7M | 0.01% |
273,606
+152,670
| +126% | +$14.3M |
|
690
Cummins
CMI
$55.8B
| $25.4M | 0.01% |
124,053
+40,186
| +48% | +$8.24M |
|
691
Blackrock
BLK
$171B
| $25.3M | 0.01% |
33,102
+6,439
| +24% | +$4.92M |
|
692
4D Molecular Therapeutics
FDMT
$324M
| $25.2M | 0.01% |
1,665,411
+17,488
| +1% | +$264K |
|
693
Chipotle Mexican Grill
CMG
$51.9B
| $24.8M | 0.01% |
783,300
-58,800
| -7% | -$1.86M |
|
694
SITE Centers
SITC
$468M
| $24.8M | 0.01% |
1,901,506
+1,861,037
| +4,599% | +$24.3M |
|
695
Natera
NTRA
$23.3B
| $24.7M | 0.01% |
607,329
-575,435
| -49% | -$23.4M |
|
|
BDXB
696
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $24.6M | 0.01% |
463,850
-6,900
| -1% | -$366K |
|
697
Alamo Group
ALG
$2.5B
| $24.5M | 0.01% |
170,640
-1,002
| -0.6% | -$144K |
|
698
Hancock Whitney
HWC
$5.35B
| $24.5M | 0.01% |
470,068
+452,528
| +2,580% | +$23.6M |
|
699
FormFactor
FORM
$2.27B
| $24.5M | 0.01% |
582,890
-20,991
| -3% | -$882K |
|
700
Synchrony
SYF
$27.8B
| $24.4M | 0.01% |
700,163
-190,577
| -21% | -$6.63M |
|